Psoriasis. Psoriasis
Conditions
Interventions
Control group: All patients admitted with a diagnosis of psoriasis will take the drug Apermilast from Abidi Pharmaceutical Company. This drug comes in a starter pack of tablets with doses of 10, 20, a
Sponsors
Cobel Darou
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults 18 years of age and older The definitive diagnosis of Psoriasis based on NPS criteria
Exclusion criteria
Exclusion criteria: Severe hypersensitivity to Apremilast Using of Apremilast in the past 3 months Active TB or incompletely treated infection Acute hepatic and renal failure Pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of serious adverse events. Timepoint: Month 2, Month 4, and Month 6 from the baseline of treatment. Method of measurement: Side effects questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Psoriasis Area and Severity Index (PASI). Timepoint: Month 4 and Month 6 from the baseline of treatment. Method of measurement: PASI (Psoriasis Area and Severity Index) questionnaire.;Assessment of weight loss. Timepoint: Month 6 from the baseline of treatment. Method of measurement: BMI Index.;Discontinuation Rate due to AEs. Timepoint: Anytime during the study. Method of measurement: Side effects questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAnahita Rahafrouz
Cobel Darou
Outcome results
None listed